Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 11588893)

1.

Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.

Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM.

Nutr Cancer. 2001;39(1):12-8.

PMID:
11588893
2.

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.

Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U; PLCO Trial.

J Natl Cancer Inst. 2006 Feb 15;98(4):245-54.

3.

Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.

Jiang L, Yang KH, Tian JH, Guan QL, Yao N, Cao N, Mi DH, Wu J, Ma B, Yang SH.

Nutr Cancer. 2010;62(6):719-27. doi: 10.1080/01635581.2010.494335.

PMID:
20661819
4.

Multivitamin/mineral supplements and prevention of chronic disease.

Huang HY, Caballero B, Chang S, Alberg A, Semba R, Schneyer C, Wilson RF, Cheng TY, Prokopowicz G, Barnes GJ 2nd, Vassy J, Bass EB.

Evid Rep Technol Assess (Full Rep). 2006 May;(139):1-117. Review.

5.

Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.

Briançon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S.

Int J Epidemiol. 2011 Dec;40(6):1605-16. doi: 10.1093/ije/dyr161.

6.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

7.

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM.

Am J Epidemiol. 2008 Apr 15;167(8):925-34. doi: 10.1093/aje/kwm389. Epub 2008 Feb 7.

8.

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center.

Grainger EM, Kim HS, Monk JP, Lemeshow SA, Gong M, Bahnson RR, Clinton SK.

Urol Oncol. 2008 Mar-Apr;26(2):125-32. doi: 10.1016/j.urolonc.2007.01.016. Epub 2007 Oct 18.

PMID:
18312929
9.

Herbal and vitamin supplement use in a prostate cancer screening population.

Barqawi A, Gamito E, O'Donnell C, Crawford ED.

Urology. 2004 Feb;63(2):288-92.

PMID:
14972473
10.

Vitamin and mineral supplement use is associated with reduced risk of prostate cancer.

Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):887-92.

11.

Dietary supplement use and medical conditions: the VITAL study.

Satia-Abouta J, Kristal AR, Patterson RE, Littman AJ, Stratton KL, White E.

Am J Prev Med. 2003 Jan;24(1):43-51.

PMID:
12554023
12.

Vitamin E supplements and risk of prostate cancer in U.S. men.

Rodriguez C, Jacobs EJ, Mondul AM, Calle EE, McCullough ML, Thun MJ.

Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):378-82.

13.

Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.

Malvy DJ, Favier A, Faure H, Preziosi P, Galan P, Arnaud J, Roussel AM, Briançon S, Hercberg S.

Cancer Detect Prev. 2001;25(5):479-85.

PMID:
11718454
14.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70.

15.

Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.

Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D.

BJU Int. 2004 May;93(7):955-60.

PMID:
15142142
16.

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.

Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE.

JAMA. 2009 Jan 7;301(1):52-62. doi: 10.1001/jama.2008.862. Epub 2008 Dec 9.

17.

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.

Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briançon S.

Arch Intern Med. 2004 Nov 22;164(21):2335-42. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):286.

18.

Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes.

Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ.

J Am Diet Assoc. 2007 Aug;107(8):1322-32.

PMID:
17659898
19.

Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?

Galan P, Briançon S, Favier A, Bertrais S, Preziosi P, Faure H, Arnaud J, Arnault N, Czernichow S, Mennen L, Hercberg S.

Br J Nutr. 2005 Jul;94(1):125-32.

PMID:
16115341
20.

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.

Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Estaquio C, Hercberg S.

Int J Cancer. 2005 Aug 20;116(2):182-6.

PMID:
15800922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk